Target intelligence / Profile preview

Central appetite and satiety circuits

Molecular classification
Other
01

Overview

The central appetite and satiety circuits comprise a sophisticated neural network, primarily centered in the hypothalamus and brainstem, that maintains energy homeostasis by integrating peripheral metabolic signals (Morton et al., 2014, Nature). This system involves the arcuate nucleus (ARC), where pro-opiomelanocortin (POMC) neurons promote weight loss and agouti-related peptide (AgRP)/neuropeptide Y (NPY) neurons promote weight gain (StatPearls, 2023). These neurons respond to circulating hormones such as leptin, insulin, and ghrelin, as well as gut-derived peptides like GLP-1, to modulate hunger and fullness via the paraventricular nucleus (PVN) and the nucleus tractus solitarius (NTS) (Cell, 2012). Dysregulation of these circuits is a hallmark of obesity, where leptin resistance or impaired satiety signaling leads to chronic overconsumption and metabolic dysfunction (Nature Reviews Endocrinology, 2017). Therapeutic strategies typically involve targeting specific receptors within these circuits, such as the GLP-1 receptor or the melanocortin-4 receptor (MC4R), to restore homeostatic balance and treat metabolic diseases (PubMed, 2021).

Other names
Hypothalamic appetite-regulating networkEnergy homeostasis circuitsMelanocortin systemHypothalamic-brainstem axisCentral feeding circuits
02

Mechanism of action

Pharmacological modulation of specific G protein-coupled receptors and neurotransmitter transporters within the hypothalamus and brainstem to shift the balance between anorexigenic (satiety-promoting) and orexigenic (hunger-promoting) signaling pathways.

03

Biological functions

Energy homeostasisAppetite regulationSatiety signalingMetabolic regulationNeuroendocrine integration
04

Disease associations

ObesityType 2 diabetesEating disordersCachexiaMetabolic syndrome
05

Safety considerations

Neuropsychiatric side effects (e.g., depression, suicidal ideation)Gastrointestinal distress (e.g., nausea, vomiting)Cardiovascular risks (e.g., increased heart rate, hypertension)Potential for drug abuse or dependencyWeight regain following treatment cessation
06

Interacting drugs

9 more in the full profile.

07

Biomarkers

Body Mass Index (BMI)Waist circumferencePlasma leptin levelsPlasma ghrelin levelsHbA1cResting energy expenditure (REE)

Beyond the preview

Go deeper on Central appetite and satiety circuits.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Central appetite and satiety circuits.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call